MESA Rail™ AIS Study - Preservation of Curve Correction

April 7, 2021 updated by: K2M, Inc.

Preservation of Thoracic Kyphosis and Coronal Curve Correction as a Function of Rod Stiffness in the Surgical Treatment of Adolescent Idiopathic Scoliosis (AIS) With the Use of the K2M MESA Rail™ Deformity System

To evaluate the restoration and maintenance of thoracic kyphosis and coronal curve correction demonstrated through the surgical implantation of the K2M MESA Rail™ Deformity System as compared to literature reported outcomes for standard Cobalt Chrome (CoCr) rod systems in the treatment of Adolescent Idiopathic Scoliosis (AIS).

Study Overview

Status

Terminated

Detailed Description

Patients treated with the Ø5.5mm or Ø4.5mm MESA Rail™ Deformity System that had:

Diagnosis of AIS requiring surgical treatment for selective non-cervical fusion with a minimum of five (5) instrumented vertebrae between T1-S1 as confirmed by patient history and radiographic studies.

AIS cases must be classified as a Lenke type 1 or type 2 curve (lumbar modifiers and thoracic sagittal profiles will be noted but not restrictive).

Age at time of surgery of ≥ 11 years old and ≤ 21 years old.

Study Type

Observational

Enrollment (Actual)

188

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

11 years to 21 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Two-hundred four (204) total subjects with the MESA Rail Deformity System at up to 18 clinical sites, geographically distributed worldwide.

Description

Inclusion Criteria:

  • Diagnosis of AIS requiring surgical treatment for selective thoracic/lumbar fusion with a minimum of five (5) instrumented vertebrae between T1-S1 as confirmed by patient history and radiographic studies. AIS cases must be classified as a Lenke type 1 or type 2 curve. No cervical vertebrae are to be incorporated into the construct.
  • Willingness and ability to comply with the requirements of the protocol including follow-up requirements.
  • Willing and able to sign a study specific informed consent form or, in the case of a patient who is a minor, provide assent and the minor patient's parent/legal guardian provides written consent to participate.
  • Age range of ≥ 11 years old and ≤ 21 years old at time of surgery.

Exclusion Criteria:

  • Previous anterior or posterior spine surgery at the index levels.
  • Previous posterior spine surgery (e.g., posterior element decompression) that destabilizes the cervical/thoracic/lumbar spine.
  • Active systemic infection or infection at the operative site.
  • Co-morbid medical conditions of the spine or upper/lower extremities that may affect the thoracic or lumbar spine neurological and/or pain assessment.
  • Metabolic bone disease such as osteoporosis that contradicts spinal surgery.
  • History of an osteoporotic fracture.
  • History of an endocrine or metabolic disorder (e.g., Paget's disease) known to affect bone and mineral metabolism.
  • Taking medications that may interfere with bony/soft tissue healing including chronic steroid use.
  • Known allergy to titanium or cobalt chrome.
  • Rheumatoid arthritis or other autoimmune disease or a systemic disorder such as HIV, active hepatitis B or C or fibromyalgia.
  • Insulin-dependent type 1 or type 2 diabetes.
  • Medical condition (e.g., unstable cardiac disease, cancer) that may result in patient death or have an effect on outcomes prior to study completion.
  • Pregnant, or intend to become pregnant, during the course of the study.
  • Severe obesity (Body Mass Index > 40).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
AIS
Surgical implantation of the K2M MESA Rail™ Deformity System in the treatment of Adolescent Idiopathic Scoliosis (AIS).
MESA Rail™ (cross-sectioned rod) with MESA pedicle screws compared to traditional rod use in the literature

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change From Baseline in Thoracic Kyphosis and Coronal Curve Correction on X-ray at 24 Months
Time Frame: Baseline (up to 90 days before surgery), 24 months

Restoration and maintenance of thoracic kyphosis and coronal curve correction.

Thoracic kyphosis (Coronal Curve): measurement of curvature from the upper endplate of T4 to the lower endplate of T12.

Baseline (up to 90 days before surgery), 24 months
Number of Participants With Adverse Events
Time Frame: Up to 24 months
Number of participants with SAE and AE for the various intervals
Up to 24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change From Baseline in Pain Scores on the Visual Analog Scale (VAS) at 24 Months
Time Frame: Baseline (up to 90 days before surgery), 24 months

Evaluation of the improvement of the Back VAS and Hip/Leg VAS (assessed together) at the 24 month post-operative visit as compared to pre-op time periods. Information on all reports of pain/numbness /tingling and the location of symptoms were captured and evaluated.

VAS scale ranged from 0 - 100mm with the 100mm accounting for the highest level of pain.

Baseline (up to 90 days before surgery), 24 months
Change From Baseline in Quality of Life Scores on the SRS-22r at 24 Months
Time Frame: Baseline (up to 90 days before surgery), 24 months

The Revised Scoliosis Research Society-22 (SRS-22r) is a specific questionnaire for spine conditions. It is applied to patients with idiopathic scoliosis, whose conditions and treatments have a great impact on their quality of life. The SRS 22r was created and revised with the purpose of evaluating this impact from the patient's point of view. The reviewed version contains 22 questions distributed into five domains: function/activity (FA), pain (P), self- image/appearance (SA), mental health (MH) and satisfaction with treatment (ST).

The scores vary from 1 to 5 in which 5 is the best health quality of life of patients.

Baseline (up to 90 days before surgery), 24 months
Patient Satisfaction
Time Frame: 12 months and 24 months
At the 12 month and 24 month follow-up visits, subjects were asked whether they were satisfied with the outcome of their surgery (Yes/No) and whether they would repeat the operation (Yes/No).
12 months and 24 months
Investigator's Rating of Subject's Clinical Disposition Using Odom's Criteria
Time Frame: 24 months

At the 24 month follow-up visit, the Investigator rated the clinical disposition of each study subject according to Odom's Criteria as follows:

Excellent: all pre-operative symptoms relieved, able to carry out daily occupations without impairment.

Good: minimum persistence of pre-operative symptoms, able to carry out daily occupations without significant interference.

Fair/Satisfactory: relief of some pre-operative symptoms but physical activity is significantly limited.

Poor: symptoms or signs unchanged or worsened.

24 months
Length of Surgery Time
Time Frame: During surgery
The length of the surgical procedure from the initial incision to final closure were captured.
During surgery
Length of Anesthesia Time
Time Frame: During surgery
The length of time the patient is under anesthesia was captured.
During surgery
Estimated Blood Loss
Time Frame: During surgery
The amount of blood loss over the entire length of the surgery was captured.
During surgery
Length of Hospital Stay
Time Frame: Admission to Discharge
The length of the hospital stay from the date of admission to the date of discharge.
Admission to Discharge
Change in Percentage of Participants Able to Return to Work/School
Time Frame: Pre-Op to 24 months
The ability to and the time it takes for the subject to be cleared to return to work/school from the date of surgery by looking at the change in percentage of participants who were able to return to work without any restrictions
Pre-Op to 24 months
Use of Narcotics Post-surgery
Time Frame: Pre-Op to 24 months
The types and dosages of any narcotics taken by the patient pre- and post-surgery was documented.
Pre-Op to 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2014

Primary Completion (Actual)

February 23, 2020

Study Completion (Actual)

February 23, 2020

Study Registration Dates

First Submitted

January 31, 2014

First Submitted That Met QC Criteria

February 12, 2014

First Posted (Estimate)

February 13, 2014

Study Record Updates

Last Update Posted (Actual)

April 12, 2021

Last Update Submitted That Met QC Criteria

April 7, 2021

Last Verified

April 1, 2021

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adolescent Idiopathic Scoliosis

Clinical Trials on MESA Rail™ Deformity System

3
Subscribe